Cadila Healthcare informs about company updates

07 Aug 2019 Evaluate

Cadila Healthcare has informed that the US FDA classifies the inspection of the Company’s Moraiya unit as OAI.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

490.30 5.90 (1.22%)
29-Mar-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 990.70
Cipla 887.85
Dr. Reddys Lab 4564.50
Lupin 652.45
Lupin 652.45
View more..